MValve technologies

About

Funding history · 2 rounds · $200.0M total

Q&A

What is MValve technologies' primary focus?

MValve technologies is dedicated to providing a solution for mitral regurgitation, an abnormal reversal of blood flow from the heart's left ventricle to the left atrium.

When was MValve technologies founded?

MValve technologies was founded in December 2011.

What is the current status of MValve technologies?

MValve technologies is currently inactive, having ceased operations in October 2018.

How many employees did MValve technologies have?

MValve technologies had 1-10 employees.

What is the total amount of funding MValve technologies raised?

MValve technologies raised a total of $200,000,000.

When was MValve technologies' last funding round?

MValve technologies' last funding round occurred in October 2015.

Which investor participated in MValve technologies' July 2014 funding round?

BSC International Holding Ltd participated in MValve technologies' July 2014 funding round.

In which sector does MValve technologies primarily operate?

MValve technologies primarily operates in the Health Tech & Life Sciences sector.

Does MValve technologies hold any patents?

Yes, MValve technologies holds 1 patent.

Team · 2

Assif Stoffman

Founder · Co-founder & CEO

LinkedIn ↗

Maurice Buchbinder

Founder · Founder

Sectors & technology

Highlights

Tags